Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 221

1.

MRI guided focal HDR brachytherapy for localized prostate cancer: Toxicity, biochemical outcome and quality of life.

Maenhout M, Peters M, Moerland MA, Meijer RP, van den Bosch MAAJ, Frank SJ, Nguyen PL, van Vulpen M, van der Voort van Zyp JRN.

Radiother Oncol. 2018 Dec;129(3):554-560. doi: 10.1016/j.radonc.2018.07.019. Epub 2018 Aug 18.

PMID:
30131183
2.

Additional hepatic 166Ho-radioembolization in patients with neuroendocrine tumours treated with 177Lu-DOTATATE; a single center, interventional, non-randomized, non-comparative, open label, phase II study (HEPAR PLUS trial).

Braat AJAT, Kwekkeboom DJ, Kam BLR, Teunissen JJM, de Herder WW, Dreijerink KMA, van Rooij R, Krijger GC, de Jong HWAM, van den Bosch MAAJ, Lam MGEH.

BMC Gastroenterol. 2018 Jun 15;18(1):84. doi: 10.1186/s12876-018-0817-8.

3.

Accuracy of SPECT/CT-based lung dose calculation for Holmium-166 hepatic radioembolization before OSEM convergence.

van Nierop BJ, Prince JF, van Rooij R, van den Bosch MAAJ, Lam MGEH, de Jong HWAM.

Med Phys. 2018 Jun 1. doi: 10.1002/mp.13024. [Epub ahead of print]

4.

Radioembolisation in Europe: A Survey Amongst CIRSE Members.

Reinders MTM, Mees E, Powerski MJ, Bruijnen RCG, van den Bosch MAAJ, Lam MGEH, Smits MLJ.

Cardiovasc Intervent Radiol. 2018 May 8. doi: 10.1007/s00270-018-1982-4. [Epub ahead of print]

5.

Focal MRI-Guided Salvage High-Dose-Rate Brachytherapy in Patients With Radiorecurrent Prostate Cancer.

Maenhout M, Peters M, van Vulpen M, Moerland MA, Meijer RP, van den Bosch MAAJ, Nguyen PL, Frank SJ, van der Voort van Zyp JRN.

Technol Cancer Res Treat. 2017 Dec;16(6):1194-1201. doi: 10.1177/1533034617741797. Epub 2017 Dec 5.

6.

Eligibility of patients for minimally invasive breast cancer therapy based on MRI analysis of tumor proximity to skin and pectoral muscle.

Merckel LG, Verburg E, van der Velden BHM, Loo CE, van den Bosch MAAJ, Gilhuijs KGA.

Breast J. 2018 Jul;24(4):501-508. doi: 10.1111/tbj.12984. Epub 2017 Dec 29.

PMID:
29286193
7.

Anatomic versus Metabolic Tumor Response Assessment after Radioembolization Treatment.

Jongen JMJ, Rosenbaum CENM, Braat MNGJA, van den Bosch MAAJ, Sze DY, Kranenburg O, Borel Rinkes IHM, Lam MGEH, van den Hoven AF.

J Vasc Interv Radiol. 2018 Feb;29(2):244-253.e2. doi: 10.1016/j.jvir.2017.09.024. Epub 2017 Dec 14.

PMID:
29249594
8.

Efficacy of Radioembolization with 166Ho-Microspheres in Salvage Patients with Liver Metastases: A Phase 2 Study.

Prince JF, van den Bosch MAAJ, Nijsen JFW, Smits MLJ, van den Hoven AF, Nikolakopoulos S, Wessels FJ, Bruijnen RCG, Braat MNGJA, Zonnenberg BA, Lam MGEH.

J Nucl Med. 2018 Apr;59(4):582-588. doi: 10.2967/jnumed.117.197194. Epub 2017 Sep 15.

PMID:
28916623
9.

Safety analysis of holmium-166 microsphere scout dose imaging during radioembolisation work-up: A cohort study.

Braat AJAT, Prince JF, van Rooij R, Bruijnen RCG, van den Bosch MAAJ, Lam MGEH.

Eur Radiol. 2018 Mar;28(3):920-928. doi: 10.1007/s00330-017-4998-2. Epub 2017 Aug 7.

10.

Early health technology assessment of magnetic resonance-guided high intensity focused ultrasound ablation for the treatment of early-stage breast cancer.

Knuttel FM, Huijsse SEM, Feenstra TL, Moonen CTW, van den Bosch MAAJ, Buskens E, Greuter MJW, de Bock GH.

J Ther Ultrasound. 2017 Aug 1;5:23. doi: 10.1186/s40349-017-0101-3. eCollection 2017.

11.

Recommendations for radioembolisation after liver surgery using yttrium-90 resin microspheres based on a survey of an international expert panel.

Samim M, van Veenendaal LM, Braat MNGJA, van den Hoven AF, Van Hillegersberg R, Sangro B, Kao YH, Liu D, Louie JD, Sze DY, Rose SC, Brown DB, Ahmadzadehfar H, Kim E, van den Bosch MAAJ, Lam MGEH.

Eur Radiol. 2017 Dec;27(12):4923-4930. doi: 10.1007/s00330-017-4889-6. Epub 2017 Jul 3.

12.

Thermal ablation of a confluent lesion in the porcine kidney with a clinically available MR-HIFU system.

van Breugel JMM, de Greef M, Wijlemans JW, Schubert G, van den Bosch MAAJ, Moonen CTW, Ries MG.

Phys Med Biol. 2017 Jul 7;62(13):5312-5326. doi: 10.1088/1361-6560/aa75b3. Epub 2017 May 30.

PMID:
28557798
13.

Perception of safety is a prerequisite for the association between neighbourhood green qualities and physical activity: Results from a cross-sectional study in Sweden.

Weimann H, Rylander L, van den Bosch MA, Albin M, Skärbäck E, Grahn P, Björk J.

Health Place. 2017 May;45:124-130. doi: 10.1016/j.healthplace.2017.03.011. Epub 2017 Mar 27.

PMID:
28359908
14.

The diagnostic performance of 18F-FDG PET/CT, CT and MRI in the treatment evaluation of ablation therapy for colorectal liver metastases: A systematic review and meta-analysis.

Samim M, Molenaar IQ, Seesing MF, van Rossum PS, van den Bosch MA, Ruers TJ, Borel Rinkes IH, van Hillegersberg R, Lam MG, Verkooijen HM.

Surg Oncol. 2017 Mar;26(1):37-45. doi: 10.1016/j.suronc.2016.12.006. Epub 2016 Dec 29. Review.

PMID:
28317583
15.

Patient Preferences for Minimally Invasive and Open Locoregional Treatment for Early-Stage Breast Cancer.

Knuttel FM, van den Bosch MA, Young-Afat DA, Emaus MJ, van den Bongard DH, Witkamp AJ, Verkooijen HM.

Value Health. 2017 Mar;20(3):474-480. doi: 10.1016/j.jval.2016.10.013. Epub 2016 Dec 22.

16.

Moderate-to-deep sedation technique, using propofol and ketamine, allowing synchronised breathing for magnetic resonance high-intensity focused ultrasound (MR-HIFU) treatment for uterine fibroids: a pilot study.

Vaessen HHB, Knuttel FM, van Breugel JMM, Ikink ME, Dieleman JM, van den Bosch MAAJ, Knape JTA.

J Ther Ultrasound. 2017 Feb 9;5:8. doi: 10.1186/s40349-017-0088-9. eCollection 2017.

17.

18F-FDG PET as novel imaging biomarker for disease progression after ablation therapy in colorectal liver metastases.

Samim M, Prevoo W, de Wit-van der Veen BJ, Kuhlmann KF, Ruers T, van Hillegersberg R, van den Bosch MAAJ, Verkooijen HM, Lam MGEH, Stokkel MPM.

Eur J Nucl Med Mol Imaging. 2017 Jul;44(7):1165-1175. doi: 10.1007/s00259-017-3637-0. Epub 2017 Feb 8.

18.

Lung Shunting: An Indicator of Survival, But Not Necessarily a Tool for Selecting Patients for Radioembolization.

Smits ML, Bastiaannet R, Prince JF, de Jong HW, van den Bosch MA, Lam MG.

Radiology. 2017 Feb;282(2):612-613. doi: 10.1148/radiol.2017162087. No abstract available.

PMID:
28099100
19.

Hepatobiliary scintigraphy may improve radioembolization treatment planning in HCC patients.

Braat MNGJA, de Jong HW, Seinstra BA, Scholten MV, van den Bosch MAAJ, Lam MGEH.

EJNMMI Res. 2017 Dec;7(1):2. doi: 10.1186/s13550-016-0248-x. Epub 2017 Jan 5.

20.

Yttrium-90 radioembolization for colorectal cancer liver metastases: a prospective cohort study on circulating angiogenic factors and treatment response.

Rosenbaum CE, van den Hoven AF, Braat MN, Koopman M, Lam MG, Zonnenberg BA, Verkooijen HM, van den Bosch MA.

EJNMMI Res. 2016 Dec;6(1):92. doi: 10.1186/s13550-016-0236-1. Epub 2016 Dec 21.

Supplemental Content

Loading ...
Support Center